5 research outputs found
Increased GABAB receptor signaling in a rat model for schizophrenia
Contains fulltext :
167879.pdf (publisher's version ) (Open Access)Schizophrenia is a complex disorder that affects cognitive function and has been linked, both in patients and animal models, to dysfunction of the GABAergic system. However, the pathophysiological consequences of this dysfunction are not well understood. Here, we examined the GABAergic system in an animal model displaying schizophrenia-relevant features, the apomorphine-susceptible (APO-SUS) rat and its phenotypic counterpart, the apomorphine-unsusceptible (APO-UNSUS) rat at postnatal day 20-22. We found changes in the expression of the GABA-synthesizing enzyme GAD67 specifically in the prelimbic- but not the infralimbic region of the medial prefrontal cortex (mPFC), indicative of reduced inhibitory function in this region in APO-SUS rats. While we did not observe changes in basal synaptic transmission onto LII/III pyramidal cells in the mPFC of APO-SUS compared to APO-UNSUS rats, we report reduced paired-pulse ratios at longer inter-stimulus intervals. The GABAB receptor antagonist CGP 55845 abolished this reduction, indicating that the decreased paired-pulse ratio was caused by increased GABAB signaling. Consistently, we find an increased expression of the GABAB1 receptor subunit in APO-SUS rats. Our data provide physiological evidence for increased presynaptic GABAB signaling in the mPFC of APO-SUS rats, further supporting an important role for the GABAergic system in the pathophysiology of schizophrenia
Recommended from our members
LRRK2 at the interface of autophagosomes, endosomes and lysosomes
Over the past 20 years, substantial progress has been made in identifying the underlying genetics of Parkinson’s disease (PD). Of the known genes, LRRK2 is a major genetic contributor to PD. However, the exact function of LRRK2 remains to be elucidated. In this review, we discuss how familial forms of PD have led us to hypothesize that alterations in endomembrane trafficking play a role in the pathobiology of PD. We will discuss the major observations that have been made to elucidate the role of LRRK2 in particular, including LRRK2 animal models and high-throughput proteomics approaches. Taken together, these studies strongly support a role of LRRK2 in vesicular dynamics. We also propose that targeting these pathways may not only be beneficial for developing therapeutics for LRRK2-driven PD, but also for other familial and sporadic cases
Sulfonated red and far-red rhodamines to visualize SNAP- and Halo-tagged cell surface proteins
The (in)ability to permeate membranes is a key feature of chemical biology probes that defines
their suitability for specific applications. Here we report sulfonated rhodamines that endow
xanthene dyes with cellular impermeability for analysis of surface proteins. We fuse charged
sulfonates to red and far-red dyes to obtain Sulfo549 and Sulfo646, respectively, and further link
these to benzylguanine and choloralkane substrates for SNAP-tag and Halo-tag labelling.
Sulfonated rhodamine-conjugated fluorophores maintain desirable photophysical properties,
such as brightness and photostability. While transfected cells with a nuclear localized SNAP-tag
remain unlabelled, extracellular exposed tags can be cleanly visualized. By multiplexing with a
permeable rhodamine, we are able to differentiate extra- and intracellular SNAP- and Halo-tags,
including those installed on the glucagon-like peptide-1 receptor, a prototypical class B G proteincoupled receptor. In more complex biological systems, Sulfo549 and Sulfo646 labelled
transfected neurons derived from induced pluripotent stem cells (iPSCs), allowing STED
nanoscopy of the axonal membrane. Together, this work provides a new avenue for rendering
dyes impermeable for exclusive extracellular visualization via self-labelling protein tags. We
anticipate that Sulfo549, Sulfo646 and their congeners will be useful for a number of cell biology
applications where labelling of intracellular sites interferes with accurate surface protein analysis
Sulfonated red and far-red rhodamines to visualize SNAP- and Halo-tagged cell surface proteins
The (in)ability to permeate membranes is a key feature of chemical biology probes that defines
their suitability for specific applications. Here we report sulfonated rhodamines that endow
xanthene dyes with cellular impermeability for analysis of surface proteins. We fuse charged
sulfonates to red and far-red dyes to obtain Sulfo549 and Sulfo646, respectively, and further link
these to benzylguanine and choloralkane substrates for SNAP-tag and Halo-tag labelling.
Sulfonated rhodamine-conjugated fluorophores maintain desirable photophysical properties,
such as brightness and photostability. While transfected cells with a nuclear localized SNAP-tag
remain unlabelled, extracellular exposed tags can be cleanly visualized. By multiplexing with a
permeable rhodamine, we are able to differentiate extra- and intracellular SNAP- and Halo-tags,
including those installed on the glucagon-like peptide-1 receptor, a prototypical class B G proteincoupled receptor. In more complex biological systems, Sulfo549 and Sulfo646 labelled
transfected neurons derived from induced pluripotent stem cells (iPSCs), allowing STED
nanoscopy of the axonal membrane. Together, this work provides a new avenue for rendering
dyes impermeable for exclusive extracellular visualization via self-labelling protein tags. We
anticipate that Sulfo549, Sulfo646 and their congeners will be useful for a number of cell biology
applications where labelling of intracellular sites interferes with accurate surface protein analysis
Extracellular clusterin limits the uptake of \u3b1-synuclein fibrils by murine and human astrocytes
The progressive neuropathological damage seen in Parkinson's disease (PD) is thought to be related to the spreading of aggregated forms of \u3b1-synuclein. Clearance of extracellular \u3b1-synuclein released by degenerating neurons may be therefore a key mechanism to control the concentration of \u3b1-synuclein in the extracellular space. Several molecular chaperones control misfolded protein accumulation in the extracellular compartment. Among these, clusterin, a glycoprotein associated with Alzheimer's disease, binds \u3b1-synuclein aggregated species and is present in Lewy bodies, intraneuronal aggregates mainly composed by fibrillary \u3b1-synuclein. In this study, using murine primary astrocytes with clusterin genetic deletion, human-induced pluripotent stem cell (iPSC)-derived astrocytes with clusterin silencing and two animal models relevant for PD we explore how clusterin affects the clearance of \u3b1-synuclein aggregates by astrocytes. Our findings showed that astrocytes take up \u3b1-synuclein preformed fibrils (pffs) through dynamin-dependent endocytosis and that clusterin levels are modulated in the culture media of cells upon \u3b1-synuclein pffs exposure. Specifically, we found that clusterin interacts with \u3b1-synuclein pffs in the extracellular compartment and the clusterin/\u3b1-synuclein complex can be internalized by astrocytes. Mechanistically, using clusterin knock-out primary astrocytes and clusterin knock-down hiPSC-derived astrocytes we observed that clusterin limits the uptake of \u3b1-synuclein pffs by cells. Interestingly, we detected increased levels of clusterin in the adeno-associated virus- and the \u3b1-synuclein pffs- injected mouse model, suggesting a crucial role of this chaperone in the pathogenesis of PD. Overall, our observations indicate that clusterin can limit the uptake of extracellular \u3b1-synuclein aggregates by astrocytes and, hence, contribute to the spreading of Parkinson pathology